People · Operator
Named in public records as an officer, director or promoter · active 2017–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sight Sciences, Inc. | — | Biotechnology | Series B | $111.3M | $778.7M | 2017 |
Staffan Encrantz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Staffan Encrantz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter Meyer | 1 | 14 |
| Andrew ` Offer | 1 | 5 |
| Stephen Thau | 1 | 4 |
| Paul Badawi | 1 | 4 |
| Jesse Selnick | 1 | 2 |
| Valeska Schroeder | 1 | 2 |
| Erica Rogers | 1 | 2 |
| David Badawi | 1 | 1 |
| Don Zurbay | 1 | 1 |
| Tommy Hicks | 1 | 1 |
| Mack Hicks | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.